These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8285831)

  • 1. Experience of an academic reference laboratory using automation for analysis of cystic fibrosis mutations.
    DeMarchi JM; Beaudet AL; Caskey CT; Richards CS
    Arch Pathol Lab Med; 1994 Jan; 118(1):26-32. PubMed ID: 8285831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience.
    Massie J; Petrou V; Forbes R; Curnow L; Ioannou L; Dusart D; Bankier A; Delatycki M
    Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):484-9. PubMed ID: 19780730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis.
    Lemna WK; Feldman GL; Kerem B; Fernbach SD; Zevkovich EP; O'Brien WE; Riordan JR; Collins FS; Tsui LC; Beaudet AL
    N Engl J Med; 1990 Feb; 322(5):291-6. PubMed ID: 2296270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal diagnosis of cystic fibrosis in a highly heterogeneous population.
    Casals T; Gimenez J; Ramos MD; Nunes V; Estivill X
    Prenat Diagn; 1996 Mar; 16(3):215-22. PubMed ID: 8710774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of prenatal carrier screening for cystic fibrosis.
    Lieu TA; Watson SE; Washington AE
    Obstet Gynecol; 1994 Dec; 84(6):903-12. PubMed ID: 7970468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New strategy for the prenatal detection/exclusion of paternal cystic fibrosis mutations in maternal plasma.
    Bustamante-Aragones A; Gallego-Merlo J; Trujillo-Tiebas MJ; de Alba MR; Gonzalez-Gonzalez C; Glover G; Diego-Alvarez D; Ayuso C; Ramos C
    J Cyst Fibros; 2008 Nov; 7(6):505-10. PubMed ID: 18573697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
    Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
    Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors.
    Kaufman DJ; Katsanis SH; Javitt GH; Murphy JA; Scott JA; Hudson KL
    Clin Genet; 2008 Oct; 74(4):367-73. PubMed ID: 18700896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 31-mutation assay for cystic fibrosis testing in the clinical molecular diagnostics laboratory.
    Wall J; Cai S; Chehab FF
    Hum Mutat; 1995; 5(4):333-8. PubMed ID: 7627189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A universal array-based multiplexed test for cystic fibrosis carrier screening.
    Amos JA; Bridge-Cook P; Ponek V; Jarvis MR
    Expert Rev Mol Diagn; 2006 Jan; 6(1):15-22. PubMed ID: 16359263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis screening at the Greenville Hospital System.
    Dacus J; Mabie B; Gailey T; Rogers C; Likes C; Metcalf L
    J S C Med Assoc; 2006 Feb; 102(1):14-6. PubMed ID: 16704181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular diagnosis of cystic fibrosis.
    Kant JA; Mifflin TE; McGlennen R; Rice E; Naylor E; Cooper DL
    Clin Lab Med; 1995 Dec; 15(4):877-98. PubMed ID: 8838228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic characterisation of circulating fetal cells allows non-invasive prenatal diagnosis of cystic fibrosis.
    Saker A; Benachi A; Bonnefont JP; Munnich A; Dumez Y; Lacour B; Paterlini-Brechot P
    Prenat Diagn; 2006 Oct; 26(10):906-16. PubMed ID: 16832834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular screening of cystic fibrosis patients.
    Fellowes AP; Murphy JM; Wesley AW; Dawson KP; George PM
    N Z Med J; 1991 Oct; 104(921):415-6. PubMed ID: 1923090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical application of analysis of microsatellite markers in the prenatal diagnosis of cystic fibrosis].
    Ferenczi A; Homolya V; Szakács G; Németh K; Kiss E; Váradi A; Fekete G
    Orv Hetil; 1997 Jan; 138(4):209-13. PubMed ID: 9072754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosensor technology for real-time detection of the cystic fibrosis W1282X mutation in CFTR.
    Feriotto G; Ferlini A; Ravani A; Calzolari E; Mischiati C; Bianchi N; Gambari R
    Hum Mutat; 2001; 18(1):70-81. PubMed ID: 11438995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal screening for cystic fibrosis: past, present and future.
    Richards CS; Grody WW
    Expert Rev Mol Diagn; 2004 Jan; 4(1):49-62. PubMed ID: 14711349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single tube multiplex PCR detection of 27 cystic fibrosis mutations and 4 polymorphisms using neonatal blood samples collected on Guthrie cards.
    Makowski GS; Nadeau FL; Hopfer SM
    Ann Clin Lab Sci; 2003; 33(3):243-50. PubMed ID: 12956437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.